Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | REGN | VRTX |
|---|---|---|
| Price | $794.67 | $521.79 |
| Change today | ▼ 0.89% | ▲ 1.05% |
| Market cap | $81.81B | $132.25B |
| Return, 3 months | +27.6% | +9.8% |
| Return, year to date | +3.4% | +15.1% |
| Return, 1 year | +38.4% | +38.5% |
| P/E (TTM) | 19.7 | 30.4 |
| P/B | 2.6 | 6.5 |
| P/E percentile vs own 5y | 63rd | 79th |
| Dividend yield | 0.46% | – |
| Revenue growth (YoY, latest qtr) | +16.7% | +12.5% |
| Net profit growth (YoY) | -6.8% | +6.5% |
| Gross margin | 84.9% | 86.0% |
| Operating margin | 26.9% | 37.9% |
| Net margin | 27.9% | 35.0% |
| Return on equity | 14.0% | 23.5% |
| Analyst target vs. price | +5.9% | +11.0% |
| Analyst buy share | 63% | 88% |
| RSI (14) | 53 | 50 |
| 30-day volatility | 26.4% | 25.7% |
| Max drawdown, 1 year | -25.9% | -15.2% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.